The glucagon-like peptide 1 analogue exendin-4 attenuates alcohol mediated behaviors in rodents
Currently, most insurance plans do not cover GLP-1 agonist weight loss medications, so patients invest directly in this proven, medically supervised path to healthier weight
The anti-inflammatory properties of both ketosis and GLP-1 therapy may help address the inflammatory component of lipedema that makes the condition resistant to traditional weight management
talk to your doctor about anti-nausea medications if needed Will it get better
A leaner market: GLP-1 weight loss drugs and the future of red meat demand Tuesday, 5 May 2026 As more people begin to take GLP-1 weight loss drugs, what influence could this have on the red meat industry
Biotech company CervoMed presented new data indicating that its oral neflamapimod treatment for dementia with Lewy bodies led to a significant reduction in widely used neurodegeneration biomarkers , including plasma glial fibrillary acidic protein and beta amyloid 42/40 ratio